Suture fixation of the levonorgestrel-releasing intrauterine device with hysteroscope for the treatment of adenomyosis in patients at high risk of device expulsion
Hysteroscopic suture fixation of the levonorgestrel-releasing intrauterine device in adenomyosis patients at high risk of expulsion successfully reduced bleeding and pain without complications.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This preprint investigated the safety and efficacy of hysteroscopic suture fixation of a levonorgestrel-releasing intrauterine device (LNG-IUD) in 21 patients with symptomatic adenomyosis who were at high risk of device expulsion, including 10 with prior LNG-IUD expulsion and 11 with no prior placement but elevated expulsion risk. Using hysteroscopy under general anesthesia, the LNG-IUD was fixed to the uterine wall near the uterine base with an ethibond suture; the study reported successful fixation in all participants, minimal blood loss, no expulsion or perforation during the observed perioperative period, and significant reductions in menstrual blood loss (PBAC) and pain (VAS) at 1 and 3 months, alongside improved hemoglobin levels in anemic patients. A key limitation stated implicitly by the design is the small, single-center preprint experience with follow-up only reported through about 3 months (and one early loss to follow-up due to pelvic infection and persistent dysmenorrhea). This paper is centrally about adenomyosis — it evaluates hysteroscopic suture fixation of an LNG-IUD to prevent expulsion and reduce adenomyosis symptoms in high-risk patients.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (23)
- Adenomyosis: epidemiological factors via openalex
- Adenomyosis: the pathophysiology of an oestrogen-dependent disease via openalex
- Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis via openalex
- Effects of short-course buserelin therapy on adenomyosis. A report of two cases. via openalex
- Elagolix to medically treat a uterine adenomyoma: A case report via openalex
- Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study via openalex
- Insertion of the Mirena Intrauterine System for Treatment of Adenomyosis-Associated Menorrhagia: A Novel Method via openalex
- Long-Term Results of Uterine Artery Embolization for Symptomatic Adenomyosis via openalex
- Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system via openalex
- Systematic review of endometriosis pain assessment: how to choose a scale? via openalex
- The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis via openalex
- Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device via openalex
- Uterine Artery Embolisation for Symptomatic Adenomyosis with Polyzene F-Coated Hydrogel Microspheres: Three-Year Clinical Follow-Up Using UFS–QoL Questionnaire via openalex
- Uterine Artery Embolization for Symptomatic Adenomyosis: 7-Year Clinical Follow-up Using UFS-Qol Questionnaire via openalex
- W2525448258 via openalex
- W2606878441 via openalex
- W2739010978 via openalex
- W2038950921 via openalex
- W3002354512 via openalex
- W1955191617 via openalex
- W3178271763 via openalex
- W2054439752 via openalex
- W6715807690 via openalex
Source provenance
- europepmc
- last seen: 2026-06-04T01:45:00.660873+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00